Vermillion (VRML) Reports In-Line Q1 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Vermillion (VRML) Reports In-Line Q1 EPS

Vermillion Reports First Quarter 2016 Results

May 16, 2016 4:01 PM EDT

AUSTIN, Texas, May 16, 2016 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported on its financial results for the first quarter ended March 31, 2016.

Valerie Palmieri, President and CEO of Vermillion, Inc., stated, "The first quarter marked a number of accomplishments, and we are on track with our 2016 commercial plan.  The FDA's clearance of Overa and the publication of our peer-reviewed clinical utility study regarding OVA1 were two of our major accomplishments in the first quarter. In addition, we launched our "Direct-to-Women" education campaign and started... More